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How splicing factors are recruited to nascent transcripts in the nucleus in order to assemble spliceosomes on newly
synthesised pre-mRNAs is unknown. To address this question, we compared the intranuclear trafficking kinetics of
small nuclear ribonucleoprotein particles (snRNP) and non-snRNP proteins in the presence and absence of splicing
activity. Photobleaching experiments clearly show that spliceosomal proteins move continuously throughout the
entire nucleus independently of ongoing transcription or splicing. Using quantitative experimental data, a
mathematical model was applied for spliceosome assembly and recycling in the nucleus. The model assumes that
splicing proteins move by Brownian diffusion and interact stochastically with binding sites located at different
subnuclear compartments. Inhibition of splicing, which reduces the number of pre-mRNA binding sites available for
spliceosome assembly, was modeled as a decrease in the on-rate binding constant in the nucleoplasm. Simulation of
microscopy experiments before and after splicing inhibition yielded results consistent with the experimental
observations. Taken together, our data argue against the view that spliceosomal components are stored in nuclear
speckles until a signal triggers their recruitment to nascent transcripts. Rather, the results suggest that splicing
proteins are constantly diffusing throughout the entire nucleus and collide randomly and transiently with pre-
mRNAs.
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Introduction
The spliceosome is the multi-megadalton machine that
catalyses pre-mRNA splicing. The building blocks of the
spliceosome are uridine-rich small nuclear RNAs (U snRNAs)
packaged as ribonucleoprotein particles (snRNPs) that
function in conjunction with numerous non-snRNP proteins
[1,2]. The major spliceosomal small nuclear ribonucleopro-
tein particles are the U1, U2, U5, and U4/U6 snRNPs. Each
snRNP consists of one or two U snRNAs (U1, U2, U5, and U4/
U6 snRNAs) bound by a protein complex that comprises
seven common Sm proteins and one or more proteins
speciﬁc to each snRNP [3]. The Sm proteins B/B9, D1, D2,
D3, E, F, and G are common to all spliceosomal snRNPs,
except U6, and are arranged into a ring structure around a
highly conserved single-stranded uridine-rich sequence of the
snRNA [4–6]. The biogenesis of spliceosomal snRNPs involves
a sequence of reactions that take place at different compart-
ments within the cell. With the exception of U6, which
acquires a c-monomethyl phosphate cap and is restricted to
the nucleus, the snRNAs are transcribed as initial precursors
that are rapidly exported to the cytoplasm where they
associate with Sm proteins [7]. Although in vitro Sm cores
assemble readily on uridine-rich RNAs, in cells this process
involves the survival of motor neurons (SMN) complex [8].
Assembly of the Sm core is a prerequisite for removal of the
snRNA 39 extension present in the precursor forms and
hypermethylation of the 59 m
7 G cap to m
2,2,7 G( m 3Go r
TMG) [3,9]. The assembled Sm core and the modiﬁed cap
then function as independent nuclear localization signals
(NLS) for subsequent reimport into the nucleus. The m3G cap
is recognized by Snurportin1, an import adaptor that
interacts with importin-b [10,11], whereas the Sm core–
mediated transport is linked to the nuclear import of SMN
[12].
Spliceosomes form anew on nascent pre-mRNAs and
disassemble after introns are excised and exons ligated. Thus,
spliceosomal snRNPs and non-snRNP proteins in the nucleus
can be either actively engaged in splicing or waiting for the
next chance to assemble a spliceosome. When the mammalian
cell nucleus is viewed with the electron microscope, spliceo-
somal components are detected in morphologically distinct
structures termed Cajal bodies (CBs), interchromatin granule
clusters (IGCs), and perichromatin ﬁbrils [13].
The CB is highly enriched in snRNPs but is devoid of non-
snRNP splicing proteins. Direct visualization of snRNPs in
living cells shows that after import into the nucleus, the newly
synthesized particles accumulate ﬁrst in CBs and are later
detected in the speckles [14]. Several lines of evidence
indicate that maturation of newly synthesized snRNPs is
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where snRNPs are recycled after spliceosome disassembly
[16,17].
The perichromatin ﬁbrils correspond to nascent tran-
scripts and appear scattered throughout the nucleoplasm,
excluding regions of condensed chromatin [18]. Perichroma-
tin ﬁbrils are often closely associated with the periphery of
IGCs, making it impossible to distinguish the two structures
within the speckled pattern that characterizes the distribu-
tion of splicing factors observed by ﬂuorescence microscopy.
Whereas snRNPs and splicing proteins detected on perichro-
matin ﬁbrils most likely correspond to active spliceosomes, a
l a r g eb o d yo fe v i d e n c ei n d i c a t e st h a tt h es p l i c e o s o m a l
components localized in IGCs are not primarily involved in
splicing [19]. Upon activation of a gene, the spliceosome
rapidly assembles on the nascent pre-mRNA [20,21]. Con-
versely, gene inactivation increases the pool of ‘‘reserve’’
splicing factors that accumulate within enlarged IGCs.
Consequently, the organization of the speckled pattern
observed by ﬂuorescence microscopy is a reﬂection of the
transcriptional and splicing activity of the cell [21,22].
Although recruitment of splicing snRNPs and non-snRNP
proteins to nascent transcripts has been visualized in several
systems, how spliceosomal components are targeted to IGCs/
nuclear speckles and what triggers their subsequent release
and recruitment to nascent transcripts remain a controver-
sial issue. Several lines of recent evidence suggest that the
formation and maintenance of nuclear structures involved in
transcription, splicing, DNA replication, and repair is
governed by self-organization principles [23–26]. To deter-
mine whether the concept of self-organization applies to
spliceosome assembly and recycling, we have compared the
kinetics of snRNP and non-snRNP spliceosomal proteins as
they move throughout the nucleus in the presence or absence
of splicing activity. The quantitative experimental data
obtained was then used for mathematical modeling. Our
results are consistent with the view that splicing proteins
move by Brownian diffusion and bind with speciﬁc on- and
off-rates to other nuclear components.
Results
Kinetics of Splicing Proteins in the Living Cell Nucleus
In the nucleus of mammalian cells, components of the
spliceosome are found distributed throughout the nucleo-
plasm, excluding nucleoli, and concentrated in nuclear
speckles or IGCs (Figure 1A); additionally, splicing snRNPs
are detected highly enriched in CBs [19,27,28]. To visualize
trafﬁcking of spliceosomal components between subnuclear
compartments, the green ﬂuorescent protein (GFP) was fused
in frame to the amino terminus of a number of splicing
proteins, including SmE, U2AF
65, U2AF
35, SF1, SC35, and
SF3a120. Western blot analysis conﬁrmed the expression of
fusion proteins with the expected molecular weight, and
ﬂuorescence microscopy showed that the GFP tag did not
affect the localization of the proteins.
Fluorescence recovery after photobleaching (FRAP) was
used to analyze the relative mobility of the splicing proteins
in the nucleoplasm, nuclear speckles, and CBs. Nuclear
speckles are identiﬁed as structures of heterogeneous size
and shape with higher ﬂuorescence intensity than the
nucleoplasm, whereas CBs appear as brighter spherical foci
approximately 0.5 lm in diameter [19,27,28]. The ﬂuores-
cence of a small area located in each of these subnuclear
compartments was irreversibly photobleached using a high-
intensity laser, and subsequent recovery due to movement of
non-bleached molecules into the bleached area was recorded
by time-lapse imaging. All GFP-tagged splicing proteins were
found to be mobile in each of the subnuclear compartments,
with half-time ﬂuorescence recoveries under 0.5 s. For all
proteins, the recovery time was systematically lower in the
nucleoplasm than in the speckles (Figure 1B and 1C).
Quantiﬁcation of FRAP recovery curves yielded effective
diffusion coefﬁcient values ranging from 0.70 to 1.84 lm
2 s
 1
in the nucleoplasm and 0.30 to 1.22 lm
2 s
 1 in the nuclear
speckles. Some of the proteins investigated (GFP-tagged SmE,
U2AF
65, and SF3a120) also showed signiﬁcant immobile
fractions in the speckles. In the case of GFP-U2AF
65, the
apparent immobile fraction recovered completely when
FRAP analysis was extended to longer periods of time (Figure
S1), indicating that the protein is transiently immobilized in
the speckles.
Next, we compared the mobility of spliceosomal compo-
nents in the presence and in the absence of splicing activity.
HeLa cells were treated with 5,6-dichlorobenzimidazole
riboside (DRB), a drug that inhibits elongation, causing
premature transcriptional termination [29]. DRB is a nucleo-
side analog that inhibits the protein kinases that phosphor-
ylate the C-terminal domain (CTD) of the largest subunit of
RNA polymerase II in vitro [30] and in vivo [31]. Time-lapse
analysis of cells expressing GFP-U2AF
65 revealed a rapid
redistribution of molecules induced by DRB (Figure 2A and
2B, and see Video S1). In less than 10 min after addition of
the drug to the medium, the GFP-U2AF
65 ﬂuorescence
decreased in the nucleoplasm and accumulated in bigger
and rounder nuclear speckles. The ﬂuorescence intensities in
the nuclear speckles and in the nucleoplasm were measured,
and the corresponding ratio was calculated over time (Figure
2G). Whereas in untreated cells, the ratio was 1.27 6 0.07 (n¼
23 speckles, 5 cells), after DRB treatment the ratio increased
to 1.42 6 0.08 (n¼25 speckles, 4 cells). In parallel, the average
area fold increase of each nuclear speckle was measured to be
PLoS Computational Biology | www.ploscompbiol.org October 2007 | Volume 3 | Issue 10 | e201 2020
Author Summary
Understanding the genomic program of an organism requires
knowledge of how the information encoded in DNA is processed to
generate messenger RNAs that can be translated into proteins. The
initial products of gene transcription are extensively modified in the
cell nucleus, and a major processing reaction consists of splicing of
specific sequences from the middle of the primary transcripts.
Splicing is catalyzed by the spliceosome, a large complex composed
of five small RNAs and over 100 different proteins. Spliceosomes
form anew on primary transcripts and disassemble after splicing, but
what triggers the recruitment of individual spliceosomal compo-
nents to selected gene products is unclear. Here, we have combined
imaging and computational approaches to address this question.
We obtained quantitative experimental data on the mobility and
subnuclear distribution of splicing proteins before and after splicing
inhibition, and we applied mathematical models to analyze and
interpret the results. We conclude that spliceosomal components do
not require a signal in order to be recruited to nascent transcripts.
Our results favor the view that splicing proteins are constantly
diffusing throughout the entire nucleus and collide randomly and
transiently with primary gene products.
Splicing Factors Diffusion and Binding2.05 6 0.81 (n¼25 speckles, 4 cells; Figure 2I). This effect was
completely reverted after removal of the drug (Figure 2D, 2E,
and 2H, and see Video S2). Despite a decrease in the relative
ﬂuorescence intensity, splicing proteins were still signiﬁ-
cantly detected in the nucleoplasm of DRB-treated cells,
indicating that spliceosomal components can localize to this
compartment even when the bulk synthesis of mRNAs is
inhibited. Our quantitative estimates further suggest that a
larger pool of splicing proteins localizes to nuclear speckles
in DRB-treated cells, consistent with the view that spliceoso-
mal components are targeted to the speckles when not
actively engaged in splicing. As more splicing proteins
localize to nuclear speckles, the projected area of these
structures become approximately 2-fold larger, whereas the
relative concentration of the molecules within the compart-
ment increases only by a factor of 1.12. Thus, the density of
binding sites for splicing proteins at the nuclear speckles
increases only marginally in response to DRB treatment.
What controls the trafﬁcking of spliceosomal components
in the nucleus is controversial. One possibility is that splicing
Figure 1. FRAP Analysis of Splicing Proteins in Different Subnuclear Compartments
FRAP experiments were performed on HeLa cells expressing GFP-tagged splicing proteins, as indicated.
(A) Images of representative cells. The circles illustrate bleach regions localized in the nucleoplasm (arrows, green circles), nuclear speckles (arrowheads,
red circles), or CBs (cb, blue circle). Bar indicates 5 lm.
(B) FRAP recovery curves of indicated GFP-tagged splicing proteins in the nucleoplasm (green curves), nuclear speckles (red curves), and CBs (blue
curve). The fluorescence intensity I was monitored over time (I was corrected for the background intensity and the amount of total fluorescence lost
during the bleach and imaging). Each recovery curve corresponds to a pool of three independent experiments, with ten different cells analyzed per
experiment. The recovery for the immobile protein GFP-coilin-PABPN1 [60] is shown for comparison (black curve).
(C) Experimental values obtained for the diffusion coefficient (D), apparent immobile fraction (I.F.), recovery time at 50% of initial fluorescence (t50%), and
recovery time at 90% of initial fluorescence (t90%) in the speckles, CBs, and nucleoplasm.
doi:10.1371/journal.pcbi.0030201.g001
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Splicing Factors Diffusion and Bindingproteins are constantly diffusing in and out of each
subnuclear compartment; alternatively (or additionally),
splicing proteins may receive signals to enter or leave a
particular compartment. To start addressing this issue, we
compared the kinetics of splicing proteins in the nucleus of
HeLa cells that were either mock-treated or treated with DRB
for 30 min. The results of FRAP experiments showed that
none of the proteins tested was signiﬁcantly immobilized in
response to the drug; on the contrary, the recovery rate
tended to be faster in DRB-treated cells (Figure 3A and 3B). It
is noteworthy that the apparent immobile fraction of GFP-
U2AF
65 is no longer detected after DRB treatment (Figure
3B), suggesting that the transient immobilization of this
splicing protein in the speckles requires ongoing tran-
scription.
The observed FRAP results imply that, irrespective of the
drug treatment, unbleached splicing proteins are constantly
moving into the bleached speckles, replacing bleached
molecules that moved out in the meantime. A more direct
demonstration that splicing proteins continue to move out of
the nuclear speckles in the absence of newly synthesized pre-
mRNA was obtained by ﬂuorescence loss in photobleaching
(FLIP). A high-intensity laser was used to irreversibly destroy
the GFP ﬂuorescence in an area that corresponded to half of
the cell nucleus (Figure 3C). The same area was repeatedly
bleached while the loss of ﬂuorescence in a non-bleached
speckle was monitored. Experiments performed on HeLa
cells treated with DRB and expressing GFP-U2AF
65, GFP-
U2AF
35, and GFP-SF1 yielded a faster ﬂuorescence loss in the
speckles when compared to untreated cells, and quantiﬁca-
tion of ﬂuorescence intensities in nuclear speckles over time
consistently revealed signiﬁcantly faster kinetics (Figure 3D–
3F). We therefore conclude that shuttling of spliceosomal
components between the nuclear speckles and the nucleo-
plasm is independent from ongoing pre-mRNA synthesis.
Furthermore, the faster ﬂuorescence recovery and decay
Figure 2. The Transcriptional Inhibitor DRB Induces a Reversible Accumulation of GFP-U2AF
65 in Enlarged Nuclear Speckles
Steady-state distribution of GFP-U2AF
65 in the nucleus of a HeLa cell after addition (A,B) or removal (D,E) of DRB.
(A,B) Depict the same cell imaged immediately after addition of DRB (A) and 35 min later (B).
(D,E) Depict the same cell imaged immediately after removal of DRB (D) and 35 min later (E). The arrows point to a nuclear speckle, the arrowheads to
the nucleoplasm. Bar indicates 5 lm.
(G,H) Plot of the ratio between fluorescence intensities in the nuclear speckles (n¼6 speckles) and in the nucleoplasm over time after addition (G) or
removal (H) of DRB. Error bars represent standard deviations.
(C,F) Depict the threshold segmentations of images in (A,B) and (D,E), revealing the outline of nuclear speckles in the presence (red outlines) and
absence (white outlines) of DRB. The nuclear boundary is outlined in yellow.
(I) Quantification of the projected areas in (C,F) reveal an approximate 2-fold increase in speckles size (n ¼ 25 speckles, 4 cells), when transcription is
inhibited by DRB.
doi:10.1371/journal.pcbi.0030201.g002
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Splicing Factors Diffusion and Bindingdetected by FRAP and FLIP experiments in cells treated with
DRB suggests that splicing factors move more freely
throughout the nucleus in the absence of transcription and
splicing. Possibly, this is because the proteins spend less time
bound to spliceosomes.
A Dominant-Negative Variant of Snurportin1 Blocks
Splicing and Redistributes Spliceosome Components
Because drugs such as DRB can cause multiple effects on
cells, we thought to use an alternative approach to inhibit
splicing activity. We took advantage of snurportin1 (SPN1), a
nuclear import adaptor that recognizes the 2,2,7-trimethyl-
guanosine (m3G) cap of spliceosomal snRNAs [10,11,32].
SPN1 is composed of two domains, an N-terminal domain
required for binding to the import receptor importin-b, and
a C-terminal m3G-cap binding region. The importin-b bind-
ing (IBB) domain comprises amino acids 1–65, and a deletion
mutant lacking these residues (SPN1DN) retains full m3G-cap
binding activity, but slows down or blocks the nuclear import
of snRNAs [10]. Thus, SPN1DN appears to compete efﬁciently
with endogenous SPN1 for binding to the m3G cap of the
spliceosomal snRNPs. Deletion of amino acids 1–65 further
prevents binding of the export receptor CRM1 to SPN1DN
[33]. As binding of SPN1 to either CRM1 or m3G cap is
mutually exclusive [33], the SPN1DN mutant most likely binds
irreversibly to spliceosomal snRNPs in a dominant-negative
way. To test this possibility, we fused either GFP or the cyan
ﬂuorescent protein (CFP) in frame to the amino terminus of
wild-type (wt) SPN1 and SPN1DN. Although SPN1 is
constantly shuttling between the nucleus and the cytoplasm,
at steady state, the protein was predominantly detected in the
cytoplasm (Figure 4A and 4B). In contrast, SPN1DN appeared
concentrated in the nucleus (Figure 4E and 4F). A deletion
mutant of snurportin1 lacking the residues 286–360
(SPN1DC) showed the same distribution as the wt protein
(Figure 4I and 4J), arguing that the changes observed for
SPN1DN distribution were not a consequence of the smaller
size of this protein when compared to wt SPN1. Double-
labeling experiments further revealed that in cells expressing
wt SPN1, the Sm proteins were normally detected throughout
the nucleoplasm, in nuclear speckles, and in CBs (Figure 4C),
whereas in cells expressing SPN1DN, the Sm proteins
accumulated in enlarged speckles and no longer concen-
trated in CBs (Figure 4G). A similar result was obtained in
cells expressing GFP-SmE (Figure 5A and 5B), and after
immunostaining with an antibody against the U2 snRNP
protein B99 (Figure 5C and 5D). As shown in Figures 4G, 5B,
and 5D, the SPN1DN mutant colocalized with snRNPs in the
nucleoplasm and in enlarged speckles, consistent with the
assumption that it binds irreversibly to the m3G cap of
snRNAs and fails to be recycled to the cytoplasm. Failure of
SPN1DN to shuttle to the cytoplasm was indeed conﬁrmed by
lack of ﬂuorescence loss in the nucleus after repeated
bleaching of the cytoplasm (Figure S2).
As snRNP proteins were no longer concentrated at CBs in
cells that expressed the SPN1DN variant, immunoﬂuores-
cence was performed using antibodies against coilin. In non-
transfected cells or in cells expressing wt SPN1, coilin was
preferentially detected as bright foci that correspond to CBs
(Figure 5E, blue foci); although CBs contain ﬁbrillarin, this
protein was observed mostly enriched at the dense ﬁbrillar
component of the nucleolus (Figure 5E, red structures).
Expression of SPN1DN caused a major relocalization of
coilin, which was no longer detected as bright foci, but rather
accumulated in the nucleolus in association with ﬁbrillarin
(note superimposition of blue and red staining at nucleoli in
Figure 5F). Another major component of CBs in normal cells
is the SMN protein. As shown in Figure 5G, double-labeling of
Figure 3. Splicing Proteins Are More Mobile in Cells Treated with DRB
FRAP (A,B) and FLIP (D–F) experiments were performed on cells mock-treated ( DRB) or treated (þDRB) with DRB for 30 min. The GFP-tagged splicing
proteins are indicated on each graph. For FRAP experiments, the bleached region was localized on a nuclear speckle. For FLIP experiments, the bleach
region corresponded to half of the cell nucleus (dashed outline in (C), and the fluorescence decay was analyzed over a nuclear speckle. Each recovery or
decay curve corresponds to a pool of three independent experiments, with ten different cells analyzed per experiment. Error bars represent standard
deviations. The differences observed in the FLIP curves between DRB treated and untreated cells are statistically significant (p , 0.0001 for GFP-U2AF
65
and GFP-U2AF
35, and p , 0.005 for SF1).
doi:10.1371/journal.pcbi.0030201.g003
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Splicing Factors Diffusion and BindingHeLa cells expressing wt SPN1 revealed complete colocaliza-
tion of SMN and coilin at CBs (indicated by arrows; note
additional minor coilin bodies that are apparently devoid of
SMN, arrowheads). Following expression of SPN1DN, SMN
dissociated from coilin (Figure 5H); SMN was still detected in
foci (Figure 5H, arrows) and was never observed in nucleoli.
In conclusion, the results show that SPN1DN induces a
redistribution of spliceosomal components similar to that
observed when cells are treated with transcription inhibitors.
To determine whether the mutant affected transcriptional
activity, cells expressing SPN1DN were incubated with 5-
ﬂuorouridine (FU) for 15 min. Living cells incorporate FU
into nascent RNA rapidly and speciﬁcally [34]. As previously
described, nascent RNA was detected as small foci throughout
the nucleoplasm and as larger structures in the nucleolus.
Similar results were observed in cells transfected with either
wt SPN1 or SPN1DN (Figure S3), indicating that the mutant
does not inhibit bulk transcriptional activity.
To examine the effect of SPN1DN expression on splicing
activity, we have used a reporter minigene transiently
expressed in HeLa cells. We have shown previously that
transcripts from this minigene are efﬁciently spliced in vivo
[35]. Cells were cotransfected with SPN1DNc o n s t r u c t s
together with the reporter plasmid, and the transcripts
derived from the reporter were analyzed 24 h post-trans-
fection by reverse transcription followed by PCR (RT-PCR).
The control cells showed three bands of approximately 375,
257, and 129 bp, as previously described [35]. The 375-bp
band corresponds to the unprocessed primary transcript; the
257-bp and the 129-bp bands result from the two alternatively
spliced transcripts obtained. The expression of wt SPN1 or
SPN1DC does not affect splicing of the reporter primary
transcript (Figure S4, lanes 6 and 8). By contrast, in cells
expressing the variant SPN1DN, there is a signiﬁcant
reduction of spliced forms relative to unprocessed primary
transcript (Figure S4, lane 4). Taken together, these results
indicate that the dominant-negative SPN1DN mutant impairs
splicing without affecting transcription.
The Mobility of Splicing Factors Is Higher in Cells That
Express SPN1DN
Having established that expression of SPN1DN inhibits
splicing in vivo, we next analyzed the mobility of splicing
proteins in cells that express this dominant-negative peptide.
HeLa cells were cotransfected with CFP fused to either wt
SPN1 or SPN1DN and GFP-tagged splicing proteins. FLIP
experiments were performed by repeatedly bleaching ap-
proximately half of the cell nucleus and monitoring the loss
of ﬂuorescence in nuclear speckles over time. The results
show that the ﬂuorescence decay curves were signiﬁcantly
faster (p , 0.0001) in cells expressing SPN1DN (Figure 6),
similar to what was observed in cells treated with DRB (Figure
3). Taken together, the results obtained by two independent
Figure 4. A Deletion Variant of Snurportin 1 Affects the Subnuclear Distribution of snRNPs
HeLa cells were transfected with either wt snurportin1 (wt SPN1) (A–D) or the deletion variants SPN1DN (E–H), and SPN1DC (I–L) fused to GFP. The cells
were labeled with mAb Y12 directed against Sm proteins.
(A,E,I) Depict the superimposition of red (Y12 antibody staining) and green (GFP-tagged protein) images.
(B,C,F,G,J,K) Depict the same cell imaged for GFP-tagged protein and Y12 staining, as indicated; arrows point to CBs and arrowheads to nuclear speckles.
Bar indicates 10 lm. (D,H,L) Show the western blot analysis of each fusion protein. Molecular weight markers (kDa) are indicated on the left.
doi:10.1371/journal.pcbi.0030201.g004
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Splicing Factors Diffusion and Bindingapproaches show that the mobility of splicing proteins in the
nucleus increases when splicing is inhibited.
Mathematical Modeling of Splicing Factor Kinetics
Previous studies proposed that splicing proteins move
within the cell nucleus by simple diffusive processes [36,37],
and that transient interactions determine the steady-state
subnuclear distribution of these molecules [38]. We applied a
mathematical model to test whether such a combination of
diffusion and binding events could explain our experimental
results. In the proposed model, we assume that splicing
factors constantly roam the nucleus and make transient
interactions with immobile targets. In the nucleoplasm, we
considered that the major binding targets are the intron-
containing nascent transcripts, whereas in the speckles, the
molecular nature of binding sites remains unclear.
Quantitative FRAP analysis of GFP-U2AF
65 in HeLa cells
treated with DRB revealed a diffusion rate of 1.58 lm
2 s
 1.
Assuming that in DRB-treated cells, splicing proteins no
longer assemble into spliceosomes (due to lack of newly
synthesized pre-mRNA), we considered this value as repre-
sentative of the effective diffusion coefﬁcient of a splicing
factor largely unaffected by binding to nascent transcripts.
Binding reactions with either nascent pre-mRNA mole-
cules or nuclear speckles slow down the apparent diffusion
rate of splicing proteins by a factor 1þk 
on;nuc/koff,nuc [39], where
k 
on;nuc is the pseudo on-rate constant in the nucleoplasm, and
koff,nuc the off-rate constant for binding sites in the nucleo-
plasm. The pseudo on-rate is by deﬁnition k 
on ¼ kon S, where
kon is the second-order association constant for the binding
reaction and S is the concentration of vacant binding sites
[39], which is assumed to remain constant. Because k 
on;nuc and
koff,nuc cannot be directly estimated from photobleaching
experiments, we empirically selected values that resulted in
FRAP and FLIP simulations consistent with the experimental
data. For untreated cells, we used koff,nuc ¼ 10 s
 1 and k 
on;nuc ¼
3.28 s
 1. As FRAP analysis of GFP-U2AF
65 showed a slower
recovery of the ﬂuorescence in nuclear speckles compared to
the nucleoplasm (Figure 1B), the koff,spk (i.e., the off-rate
constant for binding sites in the speckles) was set to 0.066 s
 1
to achieve similar recovery rates in FRAP simulations (;15 s
to recover 90% of the initial ﬂuorescence). The kon,spk value
was then chosen to achieve a ratio between steady-state
concentration of splicing proteins in the nucleoplasm and
nuclear speckles similar to the experimental data (see Figure
2). As a result, the afﬁnity (the ratio between the pseudo on-
and off-rates) of splicing proteins to nuclear speckles was
assigned a higher value than the afﬁnity to nascent transcripts
in the nucleoplasm (i.e., koff,spkn/k  
on;spk ,koff;nuc=k 
on;nuc).
To test the simulations, we further generated pure-
diffusion FRAP curves, from circular bleaching regions, with
different diffusion coefﬁcients. The radial ﬂuorescence
proﬁles from the ﬁrst post-bleach images were obtained
and analyzed as previously described [40], yielding values for
the effective diffusion coefﬁcient and immobile fraction. The
estimated diffusion coefﬁcients were in good agreement with
Figure 5. Expression of SPN1DN Induces Disassembly of Cajal Bodies and Enlargement of Speckles
HeLa cells were transfected with either wt snurportin1 (wt SPN1) (A,C,E,G) or the deletion variant SPN1DN (B,D,F,H). Cells were imaged for green, red,
and blue fluorescence.
(A) Cell cotransfected with GFP-SmE (green) and CFP-wt SPN1 (blue). Arrows point to CBs.
(B) Cell cotransfected with GFP-SmE (green) and CFP-SPN1DN (blue). Superimposition of green and blue shows a perfect colocalization of SmE and
SPN1DN in round and enlarged speckles.
(C) Cell transfected with CFP-wtSPN1 (blue) and immunolabeled with the antibody 4G3 directed against the U2 snRNP B99 protein (red). Arrows point to
CBs and arrowheads to nuclear speckles.
(D) Cell transfected with CFP-SPN1DN (blue) and immunolabeled with the antibody 4G3 (red). Superimposition of red and blue images shows
colocalization of snRNPs and SPN1DN in enlarged speckles (arrowheads).
(E) Cell transfected with GFP-wtSPN1, double-labeled with antibodies directed against coilin (blue) and fibrillarin (red); arrows point to CBs and
arrowheads to nucleoli.
(F) Cell transfected with GFP-SPN1DN, double-labeled with antibodies directed against coilin (blue) and fibrillarin (red). Note that coilin relocalized from
CBs to the nucleolus.
(G) Cell transfected with GFP-wtSPN1, double-labeled with antibodies directed against coilin (blue) and SMN protein (red). Although SMN is detected
both in the cytoplasm and in nuclear foci, the cytoplasmic staining is not well-visualized because this image was focused on CBs (arrows), which were in
a confocal plane distinct from the cytoplasm. Arrowheads indicate additional minor coilin bodies that are apparently devoid of SMN.
(H) Cell transfected with GFP-SPN1DN, double-labeled with antibodies directed against coilin (blue) and SMN (red); arrowheads point to nucleoli that
now accumulate coilin and arrows point to nuclear SMN foci. Bar indicates 10 lm.
doi:10.1371/journal.pcbi.0030201.g005
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that the Brownian motion algorithm was correctly imple-
mented.
A reduction of the concentration of available binding sites
results in a lower probability for the binding reaction to
occur. Such a reduction occurs in the nucleoplasm when
splicing is inhibited. Therefore, to model splicing inhibition,
we decreased k 
on;nuc while maintaining all other parameters
unaltered. This change was sufﬁcient to cause an increase in
the concentration of splicing proteins at nuclear speckles, as
observed experimentally (Figure 7). The increase in concen-
tration of splicing proteins at nuclear speckles increases with
decreasing k 
on;nuc values, stabilizing below a certain value
(Figure 8A). For the parameters used in the simulations,
maximum concentrations were obtained with, at least, a 100-
fold decrease in k 
on;nuc.
Theoretically, an increase in the number of splicing
proteins that at steady state localize in nuclear speckles
would also be expected if the afﬁnity of these molecules to the
speckles increased in response to splicing inhibition. This was
in fact observed by plotting the calculated ratio between the
steady-state concentration of splicing factors in the speckles
and in the nucleoplasm for increasing values of k 
on;spk (Figure
8B).
To further test which parameter best describes the
observed kinetics after splicing inhibition (i.e., decreased
k 
on;nuc , increased k 
on;spk, or a combination of both), we
performed FLIP simulations (Figure 9). The rate of ﬂuores-
cent decay under normal conditions was very similar to the
experimental data, as expected, taking into account that the
simulation parameters were chosen to be consistent with the
microscopic observations (Figure 3). Introducing a decrease
in k 
on;nuc resulted in increased rates of ﬂuorescence loss from
unbleached speckles (Figure 9B), whereas increasing the k 
on;spk
had the opposite effect (Figure 9D). Thus, decreasing the
number of nucleoplasmic binding sites in the model
parameters is sufﬁcient to reproduce the faster kinetics of
splicing proteins observed in cells when splicing is inhibited.
Furthermore, our analysis argues against the view that
splicing inhibition leads to an increased afﬁnity of splicing
proteins for the nuclear speckles, as would be expected if the
proteins were kept in the speckles until a signal triggered
their recruitment to nascent transcripts.
Discussion
In this report, we show that spliceosomal snRNP and non-
snRNP proteins are constantly roaming the entire nucleus,
moving in and out of the speckles independently of splicing
activity. Our quantitative photobleaching analysis of GFP-
tagged splicing proteins in living cells, and our mathematical
interpretation of the data, argue against the view that
spliceosomal components are stored at nuclear speckles until
a signal triggers their transit to nascent transcripts. Rather,
we propose that spliceosome assembly on pre-mRNAs relies
on a combination of continuous diffusion and transient
interactions.
To study how spliceosomal components are recruited to
newly synthesized pre-mRNAs in the nucleus, we determined
the mobility kinetics of splicing proteins in the presence or
absence of splicing activity. FRAP and FLIP experiments were
performed using a number of GFP-tagged proteins. Previous
studies conﬁrmed that chimeras of GFP fused to ASF/SF2 [21],
snRNP proteins [16,41], and SC35 [42] behave similarly to the
native proteins.
A classical approach to block splicing activity in vivo
consists in using drugs such as actinomycin D, a-amanitin, or
DRB, which primarily inhibit transcription. Here, in addition
to treating cells with DRB, we thought to inhibit splicing
activity by an independent mechanism. We show that
expression of a dominant-negative deletion mutant of the
snRNP-speciﬁc nuclear import adaptor snurportin1 (SPN1)
speciﬁcally prevents splicing of a reporter minigene. SPN1 is
an adaptor protein that binds simultaneously to the m3G-cap
structure of spliceosomal snRNAs and to the nuclear import
receptor importin-b [10,11,32]. Like other adaptor proteins,
SPN1 shuttles continuously between the nucleus and the
cytoplasm, binding cargo (snRNPs) in the cytoplasm, releasing
the cargo in the nucleus, and recycling back to the cytoplasm
without cargo. At steady state, SPN1 was predominantly
detected in the cytoplasm (Figure 4A and 4B), indicating that
the protein exits rapidly from the nucleus. SPN1 is trans-
ported out of the nucleus by the export receptor CRM1, and
binding of SPN1 to either CRM1 or m3G cap is mutually
exclusive [33]. Thus, CRM1 only exports SPN1 molecules that
have already released their snRNP cargo in the nucleus. A
SPN1 deletion mutant that lacks amino acids 1–65 (SPN1DN)
retains the capacity to bind the m3G cap but blocks nuclear
import of snRNPs because it lacks the IBB domain required
for binding to and import by importin-b [10]. Moreover,
deletion of amino acids 1–65 prevents binding of CRM1 to
SPN1 [33] and consequently impairs export of SPN1DN from
the nucleus (Figure S2). Because SPN1 binds very tightly to
the m3G cap, in the absence of the competing CRM1
interaction, snRNPs are expected to remain bound to SPN1.
In good agreement with this prediction, we observe a perfect
colocalization of snRNPs and SPN1DN (Figure 4E–4G).
SPN1DN is a small protein (,45 kDa [10]) capable of diffusing
through the nuclear pore complex [43]. In the nucleus,
SPN1DN most probably binds tightly to the m3G cap of
snRNPs, thereby blocking spliceosome assembly. Consistent
with this view, we observe that splicing of a reporter minigene
Figure 6. Expression of SPN1DN Affects the Mobility of Splicing Proteins
in Living Cells
FLIP experiments were performed on cells expressing GFP-U2AF
65 (A)
and GFP-SmE (B) together with the wt (þwt SPN1, red curves) or the
dominant-negative mutant (þSPN1DN, green curves) forms of snurpor-
tin1. The fluorescence decay was analyzed over nuclear speckles. The
results obtained for GFP-U2AF
65 and GFP-SmE in cells that were not
transfected with any SPN1 construct are also shown (black curves). Each
decay curve corresponds to a pool of three independent experiments,
with ten different cells analyzed per experiment.
doi:10.1371/journal.pcbi.0030201.g006
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unaffected by expression of SPN1DC, a deletion variant that
lacks the m3G-cap binding domain (Figure S4). Expression of
SPN1DN further induces an accumulation of snRNPs and
non-snRNP splicing proteins in enlarged nuclear speckles,
similar to what is observed following splicing inhibition by
treatment with transcription inhibitors [13,19] or micro-
injection of oligonucleotides or antibodies targeted to
disrupt splicing [22]. Potential indirect effects caused by
drug treatment have been excluded by showing that a-
amanitin does not alter the distribution of snRNPs in the
nucleus of cells that express an a-amanitin–resistant form of
RNA polymerase II [44]. Thus, it is generally accepted that the
accumulation of spliceosomal components in enlarged
nuclear speckles occurs as a consequence of splicing
inhibition.
We also show here that expression of SPN1DN causes the
disappearance of CBs with redistribution of coilin to the
nucleolus (Figure 5). Because the SPN1DN deletion mutant
blocks nuclear import of newly synthesized snRNPs [10], this
ﬁnding strengthens the view that CBs form as a result of
ongoing snRNP biogenesis in the nucleus. Indeed, several
recent studies reported the disappearance of CBs upon
depletion of SMN, which disrupted Sm core assembly; PHAX,
which blocked speciﬁcally the nuclear export of newly
synthesized U snRNAs; or hTGS1, which impaired m
7G-cap
methylation [45–47]. Additionally, CBs disassemble when
splicing is inhibited by treating cells with transcription
inhibitors [48]. This further suggests that CBs are transient
compartments, the maintenance of which requires both
ongoing biogenesis of new snRNPs and continuous recycling
of pre-existing snRNPs after each round of spliceosome
assembly.
Previous FRAP studies using GFP-tagged ASF/SF2 and SC35
revealed that these splicing proteins are in constant ﬂux and
move throughout the entire nucleus, regardless of their initial
location [37,49]. Our results show that GFP-tagged versions of
SC35, SF3a120, SF1, U2AF
65, and U2AF
35 have diffusion rates
in the nucleoplasm ranging from 1.2 to 1.4 lm
2/s. By contrast,
GFP-SmE diffuses at signiﬁcantly lower rate (0.7 lm
2/s). All
proteins recovered faster in the nucleoplasm than in the
speckles, but the difference is most striking for SmE, SF3a120,
and U2AF
65, which also showed apparent immobile fractions.
We further show that the mobility of SmE is signiﬁcantly
lower in CBs than in the nucleoplasm and similar to the
mobility observed in nuclear speckles (Figure 1B and 1C). The
dynamic exchange of several CB components has been
previously demonstrated in both mammalian cells [14,50,51]
and in Xenopus germinal vesicles [52]. In agreement with our
results, the spliceosomal snRNP core proteins SmB and SmD1
were estimated to reside in CBs for several seconds [51]. In
contrast to snRNP proteins, coilin and SMN have residence
times in CBs on the order of minutes, whereas the U4/U6
snRNP assembly factor SART3 dissociates from CBs after just
a few seconds [51].
We observed that all spliceosomal proteins are continu-
ously shuttling between the nucleoplasm and nuclear speck-
les, or between CBs, nucleoplasm, and nuclear speckles, and
Figure 7. Modeling Splicing Protein Kinetics in the Cell Nucleus
(A) The scheme illustrates the steady-state distribution of splicing
proteins when splicing is either active (Splicing ON) or inactive
(Splicing OFF). Splicing factors are represented in green and nuclear
binding sites in grey. The lower row depicts positions inside the
whole nucleus, and the upper row shows a zoom of the area
delimited by the dashed square. The large grey circle in the upper
row represents a nuclear speckle, and grey dots in the nucleoplasm
represent intron-containing nascent transcripts. Note the larger
number of splicing factors inside the nuclear speckle when splicing
is inhibited. The parameters used for binding reactions were k 
on;nuc ¼
3.28 s
 1, koff,nuc ¼ 10 s
 1, k 
on;spk ¼ 0.045 s
 1,a n dkoff,spk ¼ 0.066 s
 1
(Splicing ON). To model splicing inhibition, we assumed a decrease in
available nucleoplasmic binding sites; accordingly, the pseudo on-rate
in the nucleoplasm was decreased by a factor of approximately
30,000, k 
on;nuc ¼ 10
 4 s
 1.
(B) Color-code representation of the concentration of splicing factors
throughout the nucleoplasm and within nuclear speckles (pink squares
define dimensions and number). The simulation space corresponding to
the nucleus was divided into squares (25325 pixels), and the number of
splicing proteins inside each square was computed (Max is the maximum
value obtained in the simulations). After splicing inhibition, the number
of splicing proteins at nuclear speckles is higher. Consequently, there is
an increase in the local concentration (the pale pink squares become
dark red) as well as in the total area occupied by highly concentrated
splicing proteins (pink/red squares); this closely mimics the enlarged
nuclear speckles observed in HeLa cells treated with DRB (Figure 2B and
2D) or expressing SPN1DN (Figure 4G).
doi:10.1371/journal.pcbi.0030201.g007
Figure 8. Influence of k 
on;nuc and k 
on;spk on the Relative Concentration of
Splicing Proteins in Nuclear Speckles
The number of splicing proteins in a speckle and in an equivalent
nucleoplasmic area was counted and their ratio calculated.
(A)Thegraphplotstheratioasafunctionofk 
on;nuc.Theratioincreaseswith
decreasingk 
on;nuc values,butstabilizesbelowathresholdofapproximately
10
 1.5 s
 1.
(B) The graph plots the ratio as a function of k 
on;spk. This ratio increases
unbounded with increasing k 
on;spk values.
doi:10.1371/journal.pcbi.0030201.g008
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According to our previous estimates, GFP (27 kDa) diffuses
in cells at 33 lm
2 s
 1 [40], and an unbound GFP-fusion
protein with approximately 60 KDa is expected to diffuse at
approximately 25.3 lm
2 s
 1 [53]. The signiﬁcantly lower
diffusion rates estimated for splicing proteins (Figure 1)
suggest that these molecules are slowed down by interactions
with less-mobile nuclear components. Furthermore, the
slower recovery observed in nuclear speckles and CBs relative
to the nucleoplasm could be due to lower mobility of splicing
proteins inside these compartments, transient immobiliza-
tion caused by binding to ﬁxed structures, or a combination
of both. How long a splicing protein resides in a particular
compartment depends on its binding afﬁnity to interacting
molecules located in that compartment, and the binding
kinetics may change over time in response to speciﬁc signals.
According to the latter view, the accumulation of spliceoso-
mal components in enlarged nuclear speckles following
transcription and/or splicing inhibition could result from a
longer retention at the speckle compartment. However, the
results of photobleaching experiments depicted in Figures 3
and 6 argue against that possibility. Our FLIP data clearly
Figure 9. FLIP Simulations
(A) Schematic illustration of a simulated FLIP sequence. The green dots represent the positions of unbleached molecules, while the black dots represent
the bleached ones. The area that was repeatedly bleached corresponds to the first and the fourth quadrant of the circle that defines the nucleus. The
diffusion model was run for an initial 100 s to achieve a steady state, and then a cycle of repetitive bleaching events was started. Fluorescence was
monitored in the unbleached portion of the circle, both in a nuclear speckle and in a nucleoplasmic region of the same size, and at the same distance
from the bleached region.
(B) FLIP decay curves were generated by counting the number of fluorescent molecules inside the monitored regions at defined time intervals. For
normalization, these values are divided by the number of fluorescent molecules in those regions immediately before bleaching. Normalized FLIP
curves are then fitted by an exponential function of the form: f(t) ¼ exp( Kt), where K is the rate of fluorescence decay. Only FLIP decay curves in the
nuclear speckles are depicted. The model parameters were as follows: k 
on;spk ¼0.045 s
 1 , koff,spk¼0.066 s
 1, koff,nuc¼10 s
 1, and k 
on;nuc ¼3.28 s
 1 (blue
line) or 0.03 s
 1 (red line). The decay is faster for the lower k 
on;nuc.
(C) Plot of FLIP decay rates (K) as a function of k 
on;nuc. The decay is faster for lower k 
on;nuc values and stabilizes below approximately 10
 1.5 s
 1, which
implies at least a 100-fold reduction in the concentration of nucleoplasmic binding sites.
(D) The effect of increasing k 
on;spk. FLIP decay curves in the speckles was obtained with the following parameters: k 
on;spk ¼0.045 s
 1 (blue line) or 0.5 s
 1
(red line), koff,spk ¼0.066 s
 1, koff,nuc ¼10 s
 1, and k 
on;nuc ¼3.28 s
 1. The decay is slower for the higher k 
on;spk.
(E) Plot of FLIP decay rates (K) as a function of k 
on;spk. This decay is increasingly slower for the higher values of k 
on;spk.
doi:10.1371/journal.pcbi.0030201.g009
PLoS Computational Biology | www.ploscompbiol.org October 2007 | Volume 3 | Issue 10 | e201 2028
Splicing Factors Diffusion and Bindingdemonstrate that spliceosomal proteins are constantly
diffusing away from nuclear speckles independently of
whether splicing is active or inactive, and the rate of
ﬂuorescence loss from the speckles increased after splicing
inhibition. In agreement with these results, it was previously
reported that the nuclear mobility of GFP-ASF increased
after treating the cells with transcriptional inhibitors [37].
The ﬁnding that inhibition of splicing activity leads to
concentration of spliceosomal proteins in enlarged nuclear
speckles and yet the proteins move away from the speckles at
faster rates is counterintuitive. To address this apparent
paradox, we performed mathematical simulations using a
model that relies exclusively on stochastic processes. In our
model, splicing proteins were considered as particles moving
by Brownian diffusion. The nucleoplasm and the nuclear
speckles were considered as regions that provide binding sites
for splicing proteins. The on- and off-rates for the binding
were considered to differ in the nucleoplasm and the nuclear
speckles to be consistent with the FRAP and FLIP exper-
imental data. Inhibition of splicing, which reduces the
number of pre-mRNA binding sites available for spliceosome
assembly, was modeled as a decrease in the on-rate constant
in the nucleoplasm. Simulation of time-lapse microscopy and
FLIP experiments before and after splicing inhibition yielded
results consistent with experimental observations. Indeed, the
model reproduced both the accumulation of particles in
speckles and the faster mobility of particles. The model
assumes that under normal conditions, a diffusing particle
(representing a spliceosomal protein) can either bind to a
spliceosome in the nucleoplasm or to unknown partners in
the speckles. In a simulated steady-state situation, this results
in 11% of the particles being bound to the speckles while
22% are bound to spliceosomes in the nucleoplasm. The
remaining 67% are freely diffusing in the nucleus. By
decreasing the number of binding sites in the nucleoplasm,
splicing inhibition reduces the binding competition between
speckles and nucleoplasm. Consequently, a particle has
higher chances of binding to a speckle, becoming temporarily
part of it. As more particles bind simultaneously to nuclear
speckles, their concentration increases and the compartment
enlarges. In parallel, there are more particles diffusing
because they are no longer retained by spliceosomes in the
nucleoplasm. In the simulations, the percentage of diffusing
particles increases to 86% after the number of binding sites
in the nucleoplasm is reduced. Because there are more
particles diffusing, there is a higher chance that they will
reach the bleach region, resulting in faster loss of ﬂuores-
cence.
In conclusion, we show that the changes in kinetic behavior
observed for spliceosomal proteins following inhibition of
splicing can be reproduced in a stochastic model by simply
reducing the on-rate for binding to spliceosomes in the
nucleoplasm. Our simulations further demonstrate that
increasing the on-rate for binding to the speckles would
decrease the rate of ﬂuorescence loss from that compartment,
as opposed to the FLIP results obtained experimentally. Thus,
it is unlikely that spliceosomal components require a splicing-
dependent signal in order to leave the nuclear speckles.
Rather, we favor the view that splicing proteins are constantly
diffusing throughout the entire nucleus and collide randomly
and transiently with either pre-mRNAs or nuclear speckle
components.
Materials and Methods
Cell culture, transfection, and drug treatment. Human HeLa cells
(ECACC 93021013) were grown as monolayers in minimum essential
medium with Earle’s salts (DMEM) supplemented with 10% (v/v) fetal
calf serum, 1% (v/v) nonessential amino acids (Gibco, Invitrogen), and
2 mM L-glutamine (Gibco, Invitrogen). For live imaging, the cells
were plated in glass-bottom chambers (MatTek), and the medium was
changed to D-MEM/F-12 without phenol red, supplemented with 15
mM HEPES buffer (Invitrogen). Subconﬂuent cells were transfected
with FuGENE6 reagent (Roche Biochemicals) and analyzed at 16–24 h
after transfection. The transcription inhibitor DRB (Sigma) was used
at 75 lM from a stock solution of 11 mM in ethanol.
In vivo transcription and splicing assays. For in vivo analysis of
transcriptional activity, cells were incubated for 15 min in cell culture
medium supplemented with 2 mM 59-ﬂuoruridine (5’-FU; Sigma-
Aldrich). The incorporated 5’-FU residues were detected with a
mouse monoclonal antibody anti-BrdU (clone BU-33; Sigma). For
splicing analysis, we used the reporter plasmid IgM-Minx, which is a
chimera of IgM and AdML splicing substrates, as previously described
[35]. HeLa cells growing on 35-mm Petri dishes were cotransfected
with 1 lg of GFP-SPN1 constructs plus 200 ng of the reporter plasmid.
Immunoﬂuorescence and western blotting. For indirect immuno-
ﬂuorescence, cells were washed twice in PBS, ﬁxed with 3.7%
formaldehyde in PBS for 10 min at room temperature, and
subsequently permeabilized with 0.5% Triton X-100 in PBS for 15
min at room temperature. The cells were then rinsed in PBS
containing 0.05% Tween-20 (PBS-Tw), incubated for 60 min with
primary antibodies diluted in PBS, washed in PBS-Tw, and incubated
for 30 min with the appropriate secondary antibodies conjugated to
ﬂuorescein (FITC), indocarbocyanine (Cy3), or indodicarbocyanine
(Cy5) (Jackson ImmunoResearch Laboratories). Finally, the coverslips
were mounted in VectaShield (Vector Laboratories) and sealed with
nail polish.
We used antibodies directed against the following proteins: Sm
(mAb Y12; [54]), U2 snRNP protein B99 (mAb 4G3; [55]), coilin (rabbit
serum 204.3, kindly provided by Professor A. Lamond, University of
Dundee, United Kingdom), and ﬁbrillarin (mAb 72B9; [56]) and SMN
(mAb 2B1, a gift from Professor G. Dreyfuss, University of
Pennsylvania, Philadelphia, Pennsylvania, United States).
For western blotting analysis, protein extracts were prepared by
scrapingthecellsintoSDS-PAGEbuffer(40 mMTris-HCl [pH6.8],8%
glycerol,2.4%SDS,75mMDTT,0.01%bromophenolblue)with200U/
ml benzonzse (Sigma-Aldrich), incubating for 10 min at room temper-
ature and then boiling for 5 min. Volumes of total protein extract
equivalent to 5310
5 cells were separatedon 10% SDS-polyacrylamide
gels and transferred to nitrocellulose membranes. Western blotting
wascarriedoutusingasemidryelectrophoretictransfercell.Blotswere
probed with anti-GFP monoclonal antibody (Roche Applied Sciences)
in 2.5% milk-PBS and developed using peroxidase-conjugated goat
anti-mouse IgG (BioRad Laboratories). Bands were visualized using
ECL (Amersham Biosciences).
Plasmids and constructs. The following GFP-tagged proteins were
used: GFP-SmE (kindly provided by Professor A. Lamond), GFP-SC35
(a gift from Dr. Jan-Peter Kreivi, Uppsala University, Sweden), GFP-
U2AF
65 and GFP-U2AF
35 [57], GFP-SF3a120 (a gift from Professor
Angela Kra ¨mer, University of Geneva, Switzerland), and GFP-SF1.
The cDNA of SF1 (Y08766) was obtained from pGEM/SF1 (a gift from
Professor Angela Kra ¨mer) and cloned in the Bam HI site of pEGFP-
C1 (Clontech). The pET28 snurportin1 constructs [10] were digested
with Nco I, followed by a ﬁll-in reaction, digestion with Bam HI, and
cloning into the Sma I and Bam HI sites of pECFP-C1, pEGFP-C1, and
pEGFP-N3 vectors. All constructs were puriﬁed using plasmid DNA
midi-prep kit (QIAGEN) and sequenced.
Live cell microscopy. Live cells were imaged at 37 8C maintained by
a heating/cooling frame (LaCon,) in conjunction with an objective
heater (PeCon). Images were acquired on a Zeiss LSM 510 confocal
microscope (Carl Zeiss) using a PlanApochromat 633/1.4 objective.
GFP ﬂuorescence was detected using the 488-nm laser line of an Ar
laser (25 mW nominal output) and a LP 505 ﬁlter. Time-lapse 3D
imaging of selected cells was performed on the confocal microscope
immediately after DRB treatment and/or DRB removal. For this, a
total of up to 200 z-stack series were acquired over time for each cell,
each z-stack having between 15 and 20 images and with 0.60 lmo f
distance between each image in the stack. Image size was 512 3 512
pixels, and the pixel width was 72 nm. The time between each z-stack
acquisition depended on its number of images, and varied between 20
s and 60 s. Maximum projection images were generated from each z-
stack and processed with ImageJ (http://rsb.info.nih.gov/ij/) using a
rigid body registration algorithm to correct for cell displacement
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of DRB were then generated and time-annotated. Fluorescence
intensity values in nuclear speckles and nucleoplasmic regions were
measured over time in registered projection images also using
ImageJ.
FLIP analysis. In each FLIP experiment, cells were repeatedly
bleached in a region of interest (ROI) that corresponded to half of the
total nuclear area, and imaged between bleach pulses. Bleaching was
performed by scanning the deﬁned ROI with three iterations of the
488-nm laser line, at maximum intensity. Bleach pulse duration
ranged from 2.2 to 3.1 s, depending on the size of the bleached
region. Repetitive bleach pulses were achieved using the FLIP Macro
for LSM software release 2.8, developed by Gwe ´nae ¨l Rabut, at the
EMBL (http://www.embl-heidelberg.de/ExternalInfo/ellenberg/
homepage/macros.html). Image size was 512 3 512 pixels, and the
pixel width was 48 nm. For imaging, the laser power was attenuated to
0.1%–0.2% of the bleach intensity. Images were background
subtracted and registered to correct for cell displacement during
image acquisition using ImageJ. Fluorescence intensity values in
nuclear speckles and nucleoplasmic regions were measured over time
in registered projection images using ImageJ. The data were then
normalized to correct for loss of ﬂuorescence due to image
acquisition, using non-bleached cells to estimate imaging bleach
kinetics. Loss of ﬂuorescence due to imaging could reach 10%–20%
over the time course of the experiment.
Quantitative FRAP analysis. FRAP experiments were performed
essentially as described [40]. Each FRAP experiment started with
three image scans followed by a bleach pulse of 110 ms on a spot with
a diameter of 25 pixels (0.59-lm radius). A series of 97 single-section
images (of size 512350 and pixel width 48 nm) was then collected at
intervals of 78.40 ms, again with the ﬁrst image acquired 2 ms after
the end of bleaching. For FRAP performed during a longer time, all
parameters were kept the same, except the number of images, which
was increased to 997 (total duration of acquisition thus increased to
;80 s). For imaging, the laser power was attenuated to 1% of the
bleach intensity. FRAP time series were analyzed as described [40]. All
ﬁtting procedures were performed using the NonLinearRegress
function of Mathematica 5.0 (Wolfram Research).
Mathematical modeling. In our model, the nucleoplasm and
nuclear speckles were deﬁned as circular regions with radii 8 lm
and 0.7 lm, respectively, and the number of speckles was ns¼14. The
Brownian motion algorithm was based on a modiﬁcation of the Box-
Mu ¨ller algorithm [58] to generate random deviates with Gaussian
distribution and standard deviation equal to
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2DfreeDt
p
in each spatial
direction. Typically Dt (the time between each simulation step) was
set to 0.01 s, which yields a standard deviation of approximately 0.17
lm, less than the size of a nuclear speckle. The effective diffusion
coefﬁcient was set to Dfree¼1.58 lm
2 s
 1 based on the value estimated
by FRAP experiments for GFP-U2AF65 in DRB-treated cells. Binding
reactions slow the apparent diffusion rate of molecules by a factor 1þ
k 
on;nuc /koff,nuc [39]. The probability for the binding reaction to occur is
pbind¼1 exp ð k 
onDtÞ, whereas the probability for a bound molecule
to break its interaction is punbind¼1 exp( koffDt). These probabilities
are position-dependent, being different for the nucleoplasm and the
speckles. Within the nucleoplasm and the nuclear speckles, we
assumed that binding sites were distributed homogeneously. The
values for kon and koff were empirically selected from FRAP and FLIP
simulations.
FRAP and FLIP simulations were generated using a Monte Carlo
approach. At least 10
5 molecules were simulated. The probability that
a ﬂuorescent molecule is bleached is pbleach ¼ 1   exp( KBDt) inside
the bleaching region. For FRAP simulations, the bleach region
consisted of a circular area (0.7-lm radius) positioned either in the
nucleoplasm or in a nuclear speckle, and for FLIP simulations, half of
the circle representing the nucleus was bleached. In a simulation step,
for each molecule, a random number a with uniform probability
density was generated in the interval [0,1]. The random number
generator used is based on an implementation (http://fmg-www.cs.
ucla.edu/fmg-members/geoff/mtwist.html) of the Mersenne-Twister
algorithm [59], which generates deviates with uniform distribution.
For a non-bound molecule, the binding reaction occurs if a , pBind.I f
a . pBind, then the molecule moves to another random location
according to the Brownian motion algorithm. Molecules are con-
strained to move inside the nucleus. Bound molecules maintain their
current coordinates and are freed from their sites only if a , punbind.
Fluorescent molecules are bleached if the particle is located inside
the bleach region and if a random number b in the interval [0,1] is
smaller than pbleach. FRAP and FLIP curves were generated by counting
at deﬁned time intervals the number of ﬂuorescent molecules inside
either the bleached or unbleached regions, respectively.
Supporting Information
Figure S1. GFP-U2AF
65 Is Transiently Immobilized in Nuclear
Speckles
FRAP experiments were performed on HeLa cells expressing GFP-
tagged U2AF
65. The panel shows the FRAP recovery curve in nuclear
speckles. This curve corresponds to a pool of three independent
experiments, with ten different cells analyzed per experiment.
Found at doi:10.1371/journal.pcbi.0030201.sg001 (1.2 MB TIF).
Figure S2. The Mutant SPN1DN Fails To Be Exported from the
Nucleus
FLIP experiments were performed on HeLa cells expressing GFP-wt
SPN1 or GFP-SPN1DN. The wild-type protein is predominantly
detected in the cytoplasm. However, the ﬂuorescence in the
cytoplasm decays following repeated bleaching of the nucleus,
indicating that the protein shuttles between the two compartments.
In contrast, the intensity of GFP-SPN1DN ﬂuorescence in the nucleus
remains constant after repeated bleaching of the cytoplasm, indicat-
ing that this mutant protein is not shuttling. Each decay curve
corresponds to six different cells analyzed. Fluorescence values were
corrected for bleaching due to imaging, using ten different
unbleached cells imaged in the same conditions. Error bars represent
standard deviations.
Found at doi:10.1371/journal.pcbi.0030201.sg002 (2.4 MB TIF).
Figure S3. Expression of SPN1DN Does Not Affect Transcriptional
Activity
HeLa cells were transfected with either wtSPN1 (A–C) or the deletion
mutant SPN1DN (D–F). Cells were incubated with 59-ﬂuoruridine (5’-
FU) for 15 min. Living cells incorporate 59-FU into nascent RNA,
which is visualized with antibodies against halogenated nucleotides
(red staining in (B,C,E,F)), showing that global transcription is active
in both transfected cells. Bar indicates 10 lm.
Found at doi:10.1371/journal.pcbi.0030201.sg003 (3.2 MB TIF).
Figure S4. Expression of SPN1DN Impairs Splicing
RT-PCR analysis of HeLa cells that were either transfected with a
splicing reporter minigene (lanes 2 and 3) or cotransfected with the
reporter minigene together with GFP-SPN1DN (lanes 4 and 5), GFP-
SPN1DC (lanes 6 and 7), or GFP-wtSPN1 (lanes 8 and 9). Controls
lacking reverse transcriptase indicate no contamination with plasmid
DNA (lanes 3, 5, 7, and 9). The structure of each transcript is
illustrated on the right. Molecular weight markers (kDa) are indicated
on the left.
Found at doi:10.1371/journal.pcbi.0030201.sg004 (3.2 MB TIF).
Video S1. Live-Cell Movie Played at 750 Times Its Real Speed Showing
Redistribution of GFP-Tagged U2AF
65 after Addition of DRB to the
Cell Medium
In less than 10 min after addition of the drug, GFP-U2AF
65
ﬂuorescence decreased in the nucleoplasm and accumulated in
bigger, rounder speckles.
Found at doi:10.1371/journal.pcbi.0030201.sv001 (6.2 MB AVI).
Video S2. Live-Cell Movie Showing Redistribution of GFP-Tagged
U2AF
65 after Removal of DRB to the Cell Medium
The effect of the drug as shown in Video S1 is completely reversible.
Found at doi:10.1371/journal.pcbi.0030201.sv002 (10.3 MB AVI).
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